Get the initial IRB submission right the first time.
Initial IRB Submission: 7 Fundamentals of Success
Related Posts
Vivacity-MG3 Trial Confirms Nipocalimab’s Efficacy, Safety in Treating Generalized Myasthenia Gravis
Credit: Andrii | stock.adobe.com Data from the Phase III Vivacity-MG3 trial (NCT04951622) show the investigational therapy nipocalimab improved the symptoms of generalized myasthenia gravis (gMG) […]
First Patient Treated With Investigational ABBV-383 in CERVINO Phase III Study for Multiple Myeloma
Image Credit: © Катерина Євтехова – stock.adobe.com AbbVie has announced that the first patient has been treated with its investigational ABBV-383 in the CERVINO Phase […]
Safeguarding Against Trial Complexities With Feasibility Studies
ACT: How can feasibility studies be used to safeguard against trial complexities? Nambisan: So I touched on this just briefly in my prior response. But […]